Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/1269
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorCRIADO, Paulo R.-
dc.contributor.authorAVANCINI, Joao-
dc.contributor.authorSANTI, Claudia G.-
dc.contributor.authorMEDRADO, Ana T. Amoedo-
dc.contributor.authorRODRIGUES, Carlos E.-
dc.contributor.authorCARVALHO, Jozelio F. de-
dc.date.accessioned2013-07-30T17:17:33Z-
dc.date.available2013-07-30T17:17:33Z-
dc.date.issued2012-
dc.identifier.citationISRAEL MEDICAL ASSOCIATION JOURNAL, v.14, n.9, p.577-582, 2012-
dc.identifier.issn1565-1088-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1269-
dc.description.abstractThe DRESS syndrome (drug reaction with eosinophilia and systemic symptoms), also known as DIHS (drug-induced hypersensitivity syndrome), presents clinically as an extensive mucocutaneous rash, accompanied by fever, lymphadenopathy, hepatitis, hematologic abnormalities with eosinophilia and atypical lymphocytes, and may involve other organs with eosinophilic infiltration, producing damage in several systems, especially kidney, heart, lungs, and pancreas. The pathogenesis is related to specific drugs (especially the aromatic anticonvulsants), altered immune response, sequential reactivation of herpes virus, and association with some HLA alleles. Glucocorticoids are the basis for the treatment of the syndrome, which may be given with intravenous immunoglobulin and, in selected cases, ganciclovir. This article reviews current concepts regarding the interaction of drugs, viruses and immune responses during this complex adverse-drug reaction.-
dc.description.sponsorshipFederico Foundation-
dc.description.sponsorshipCNPq [300665/2009-1]-
dc.language.isoeng-
dc.publisherISRAEL MEDICAL ASSOC JOURNAL-
dc.relation.ispartofIsrael Medical Association Journal-
dc.rightsrestrictedAccess-
dc.subjectdrug reaction with eosinophilia and systemic symptoms (DRESS syndrome)-
dc.subjectdrug-induced hypersensitivity syndrome (DIHS)-
dc.subjectexanthema-
dc.subjectherpes virus-
dc.subjecthepatitis-
dc.subjectnephritis-
dc.subject.otherinduced hypersensitivity syndrome-
dc.subject.otherhuman-herpesvirus-6 reactivation-
dc.subject.othert-cells-
dc.subject.othercarbamazepine-
dc.subject.otherinfection-
dc.subject.otherhypogammaglobulinemia-
dc.subject.otheranticonvulsants-
dc.subject.otherassociation-
dc.subject.otherallergy-
dc.subject.otherboy-
dc.titleDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Complex Interaction of Drugs, Viruses and the Immune System-
dc.typearticle-
dc.rights.holderCopyright ISRAEL MEDICAL ASSOC JOURNAL-
dc.identifier.pmid23101424-
dc.subject.wosMedicine, General & Internal-
dc.type.categoryreview-
dc.type.versionpublishedVersion-
hcfmusp.author.externalAVANCINI, Joao:Univ Sao Paulo, Fac Med, Hosp Clin, Dept Dermatol, Sao Paulo, Brazil-
hcfmusp.author.externalMEDRADO, Ana T. Amoedo:Inst Med Especializada IMME, Feira De Santana, BA, Brazil-
hcfmusp.author.externalRODRIGUES, Carlos E.:Univ Fortaleza Unifor, Dept Med, Fortaleza, Ceara, Brazil-
hcfmusp.author.externalCARVALHO, Jozelio F. de:Univ Fed Bahia, Sch Med, Hosp Univ Prof Edgard Santos, Div Rheumatol, Salvador, BA, Brazil-
hcfmusp.description.beginpage577-
hcfmusp.description.endpage582-
hcfmusp.description.issue9-
hcfmusp.description.volume14-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84871887796-
hcfmusp.origem.idWOS:000309624900014-
hcfmusp.publisher.cityRAMAT GAN-
hcfmusp.publisher.countryISRAEL-
hcfmusp.relation.referenceAihara Y, 2003, BRIT J DERMATOL, V149, P165, DOI 10.1046/j.1365-2133.2003.05368.x-
hcfmusp.relation.referenceAires NB, 2006, DIAGN TRATAMENTO, V112, P86-
hcfmusp.relation.referenceBocquet H, 1996, SEMIN CUTAN MED SURG, V15, P250, DOI 10.1016/S1085-5629(96)80038-1-
hcfmusp.relation.referenceBohan KH, 2007, PHARMACOTHERAPY, V27, P1425, DOI 10.1592/phco.27.10.1425-
hcfmusp.relation.referenceCHANG DKM, 1992, SEMIN NEUROL, V12, P329, DOI 10.1055/s-2008-1041189-
hcfmusp.relation.referenceCriado PR, 2002, REV BRAS CLIN TERAP, V28, P59-
hcfmusp.relation.referenceCriado PR, 2004, J DERMATOL, V31, P1009-
hcfmusp.relation.referenceDescamps V, 2010, ANN DERMATOL VENER, V137, P703, DOI 10.1016/j.annder.2010.04.024-
hcfmusp.relation.referenceEshki M, 2009, ARCH DERMATOL, V145, P67, DOI 10.1001/archderm.145.1.67-
hcfmusp.relation.referenceFernando SL, 2009, AM J DERMATOPATH, V31, P611, DOI 10.1097/DAD.0b013e3181a18d64-
hcfmusp.relation.referenceFiszenson-Albala F, 2003, BRIT J DERMATOL, V149, P1018, DOI 10.1111/j.1365-2133.2003.05584.x-
hcfmusp.relation.referenceFittje M, 2001, INTERNET J NEUROL, V1, DOI [10.5580/2458, DOI 10.5580/2458]-
hcfmusp.relation.referenceGaneva M, 2008, INT J DERMATOL, V47, P853, DOI 10.1111/j.1365-4632.2008.03637.x-
hcfmusp.relation.referenceGentile I, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-49-
hcfmusp.relation.referenceKano Y, 2006, BRIT J DERMATOL, V155, P301, DOI 10.1111/j.1365-2133.2006.07238.x-
hcfmusp.relation.referenceKano Y, 2004, ARCH DERMATOL, V140, P183, DOI 10.1001/archderm.140.2.183-
hcfmusp.relation.referenceKano Y, 2010, MED CLIN N AM, V94, P743, DOI 10.1016/j.mcna.2010.03.004-
hcfmusp.relation.referenceKennebeck G A, 2000, J Am Board Fam Pract, V13, P364-
hcfmusp.relation.referenceKito Y, 2012, ACTA DERM-VENEREOL, V92, P100, DOI 10.2340/00015555-1168-
hcfmusp.relation.referenceKosseifi Semaan G, 2006, J Occup Med Toxicol, V1, P9, DOI 10.1186/1745-6673-1-9-
hcfmusp.relation.referenceNaisbitt DJ, 2003, J ALLERGY CLIN IMMUN, V111, P1393, DOI 10.1067/mai.2003.1507-
hcfmusp.relation.referenceOskay T, 2006, EPILEPSY RES, V70, P27, DOI 10.1016/j.eplepsyres.2006.02.006-
hcfmusp.relation.referencePicard D, 2010, SCI TRANSL MED, V2, P46-
hcfmusp.relation.referencePinana E, 2010, J CLIN PHARM THER, V35, P365, DOI 10.1111/j.1365-2710.2009.01081.x-
hcfmusp.relation.referenceSeishima M, 2006, BRIT J DERMATOL, V155, P344, DOI 10.1111/j.1365-2133.2006.07332.x-
hcfmusp.relation.referenceSHEAR NH, 1988, J CLIN INVEST, V82, P1826, DOI 10.1172/JCI113798-
hcfmusp.relation.referenceShiohara Tetsuo, 2006, Allergol Int, V55, P1, DOI 10.2332/allergolint.55.1-
hcfmusp.relation.referenceShiohara T, 2007, CLIN REV ALLERG IMMU, V33, P124, DOI 10.1007/s12016-007-8010-9-
hcfmusp.relation.referenceShiohara T, 2007, BRIT J DERMATOL, V156, P1083, DOI 10.1111/j.1365-2133.2007.07807.x-
hcfmusp.relation.referenceSullivan JR, 2001, ARCH DERMATOL, V137, P357-
hcfmusp.relation.referenceTohyama M, 2011, J DERMATOL, V383, P228-
hcfmusp.relation.referenceVITTORIO CC, 1995, ARCH INTERN MED, V155, P2285, DOI 10.1001/archinte.155.21.2285-
hcfmusp.relation.referenceWu Y, 2006, J ALLERGY CLIN IMMUN, V118, P233, DOI 10.1016/j.jaci.2006.03.005-
hcfmusp.relation.referenceYoshikawa T, 2006, J CLIN VIROL, V37, pS92, DOI 10.1016/S1386-6532(06)70019-1-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipCNPq-
hcfmusp.remissive.sponsorshipFederico Foundation-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus74-
hcfmusp.scopus.lastupdate2024-02-23-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/53
LIM/53 - Laboratório de Micologia


Files in This Item:
File Description SizeFormat 
art_CRIADO_Drug_Reaction_with_Eosinophilia_and_Systemic_Symptoms_(DRESS)_2012.PDF
  Restricted Access
publishedVersion (English)178.4 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.